Literature DB >> 2478465

Expression of viral and myelin gene transcripts in a murine CNS demyelinating disease caused by a coronavirus.

C A Jordan1, V L Friedrich, C Godfraind, C B Cardellechio, K V Holmes, M Dubois-Dalcq.   

Abstract

C57BI/6N mice develop a CNS demyelinating disease when inoculated intracranially at 4 weeks of age with the A59 strain of mouse hepatitis virus (MHV-A59). In order to explore the virus-host interactions, the histological features of the demyelinating disease were correlated with the spatial and temporal distribution of viral transcripts and the expression of oligodendrocyte-specific genes (myelin basic protein, proteolipid protein, myelin-associated glycoprotein, and 2',3' cyclic nucleotide 3'-phosphohydrolase) in the spinal cord of diseased mice. Three distinct phases in the disease were identified. In the first phase, 1 week postinfection (1 WPI), virus replication was widespread in both gray and white matter but was preferentially occurring in glial cells. In the ventral and dorsal root zones where viral transcripts were most abundant, all myelin gene transcripts were decreased before demyelination was seen. During the second phase of the disease (2-3 WPI), viral transcripts decreased in abundance and became restricted to the white matter. Numerous demyelinating lesions were observed and were characterized by inflammatory cells, paucity of oligodendrocytes, and a profound decrease of all myelin gene transcripts. In the third phase of the disease (4-6 WPI) no viral transcripts were detected, and remyelination began. In the lesions and the tissue surrounding them, transcripts of all myelin genes increased to levels above normal. The increased expression of myelin gene transcripts occurred in a synchronized manner and with a cellular distribution reminiscent of that seen in developmental myelination. These molecular events correlated with efficient remyelination and clinical recovery in this murine demyelinating disease.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2478465      PMCID: PMC7165873          DOI: 10.1002/glia.440020505

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  36 in total

1.  Three intergenic regions of coronavirus mouse hepatitis virus strain A59 genome RNA contain a common nucleotide sequence that is homologous to the 3' end of the viral mRNA leader sequence.

Authors:  C J Budzilowicz; S P Wilczynski; S R Weiss
Journal:  J Virol       Date:  1985-03       Impact factor: 5.103

Review 2.  Biology of disease. Analysis of autoimmune demyelination: its impact upon multiple sclerosis.

Authors:  C S Raine
Journal:  Lab Invest       Date:  1984-06       Impact factor: 5.662

3.  Monoclonal antibodies to gel-excised glial filament protein and their reactivities with other intermediate filament proteins.

Authors:  V M Lee; C D Page; H L Wu; W W Schlaepfer
Journal:  J Neurochem       Date:  1984-01       Impact factor: 5.372

4.  Identification of Theiler's virus infected cells in the central nervous system of the mouse during demyelinating disease.

Authors:  C Aubert; M Chamorro; M Brahic
Journal:  Microb Pathog       Date:  1987-11       Impact factor: 3.738

5.  Persistence of mouse hepatitis virus A59 RNA in a slow virus demyelinating infection in mice as detected by in situ hybridization.

Authors:  E Lavi; D H Gilden; M K Highkin; S R Weiss
Journal:  J Virol       Date:  1984-08       Impact factor: 5.103

6.  Antigenic assessment of coronaviruses isolated from patients with multiple sclerosis.

Authors:  J O Fleming; F A el Zaatari; W Gilmore; J D Berne; J S Burks; S A Stohlman; W W Tourtellotte; L P Weiner
Journal:  Arch Neurol       Date:  1988-06

7.  Oligodendroglial expression and deposition of four major myelin constituents in the myelin sheath during development. An in vivo study.

Authors:  M Monge; D Kadiiski; C M Jacque; B Zalc
Journal:  Dev Neurosci       Date:  1986       Impact factor: 2.984

8.  Developmental expression of myelin proteolipid, basic protein, and 2',3'-cyclic nucleotide 3'-phosphodiesterase transcripts in different rat brain regions.

Authors:  J Kanfer; M Parenty; C Goujet-Zalc; M Monge; L Bernier; A T Campagnoni; A Dautigny; B Zalc
Journal:  J Mol Neurosci       Date:  1989       Impact factor: 3.444

9.  A technique for ultracryotomy of cell suspensions and tissues.

Authors:  K T Tokuyasu
Journal:  J Cell Biol       Date:  1973-05       Impact factor: 10.539

10.  Adoptive transfer of EAE-like lesions from rats with coronavirus-induced demyelinating encephalomyelitis.

Authors:  R Watanabe; H Wege; V ter Meulen
Journal:  Nature       Date:  1983 Sep 8-14       Impact factor: 49.962

View more
  16 in total

1.  The relationship between viral RNA, myelin-specific mRNAs, and demyelination in central nervous system disease during Theiler's virus infection.

Authors:  M Yamada; A Zurbriggen; R S Fujinami
Journal:  Am J Pathol       Date:  1990-12       Impact factor: 4.307

2.  Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor beta(delta).

Authors:  J M Peters; S S Lee; W Li; J M Ward; O Gavrilova; C Everett; M L Reitman; L D Hudson; F J Gonzalez
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

3.  Genetic restriction of murine hepatitis virus type 3 expression in liver and brain: comparative study in BALB/c and C3H mice by immunochemistry and hybridization in situ.

Authors:  D Décimo; O Boespflug; M Meunier-Rotival; M Hadchouel; M Tardieu
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

4.  Thymus involution induced by mouse hepatitis virus A59 in BALB/c mice.

Authors:  C Godfraind; K V Holmes; J P Coutelier
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

5.  In vitro analysis of the oligodendrocyte lineage in mice during demyelination and remyelination.

Authors:  R Armstrong; V L Friedrich; K V Holmes; M Dubois-Dalcq
Journal:  J Cell Biol       Date:  1990-09       Impact factor: 10.539

6.  Leukemia/lymphoma-related factor (LRF) exhibits stage- and context-dependent transcriptional controls in the oligodendrocyte lineage and modulates remyelination.

Authors:  Nathan L Davidson; Fengshan Yu; Naruchorn Kijpaisalratana; Tuan Q Le; Laurel A Beer; Kryslaine L Radomski; Regina C Armstrong
Journal:  J Neurosci Res       Date:  2017-05-30       Impact factor: 4.164

7.  Exon 2 containing myelin basic protein (MBP) transcripts are expressed in lesions of experimental allergic encephalomyelitis (EAE).

Authors:  K Nagasato; R W Farris; M Dubois-Dalcq; R R Voskuhl
Journal:  J Neuroimmunol       Date:  1997-01       Impact factor: 3.478

8.  Machine learning approach identifies new pathways associated with demyelination in a viral model of multiple sclerosis.

Authors:  Reiner Ulrich; Arno Kalkuhl; Ulrich Deschl; Wolfgang Baumgärtner
Journal:  J Cell Mol Med       Date:  2009-01-14       Impact factor: 5.310

Review 9.  The multifaceted role of astrocytes in regulating myelination.

Authors:  Hülya Kıray; Susan L Lindsay; Sara Hosseinzadeh; Susan C Barnett
Journal:  Exp Neurol       Date:  2016-03-14       Impact factor: 5.330

Review 10.  Pathogenesis of virus-induced demyelination.

Authors:  J K Fazakerley; M J Buchmeier
Journal:  Adv Virus Res       Date:  1993       Impact factor: 9.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.